962 related articles for article (PubMed ID: 20944000)
1. IDO upregulates regulatory T cells via tryptophan catabolite and suppresses encephalitogenic T cell responses in experimental autoimmune encephalomyelitis.
Yan Y; Zhang GX; Gran B; Fallarino F; Yu S; Li H; Cullimore ML; Rostami A; Xu H
J Immunol; 2010 Nov; 185(10):5953-61. PubMed ID: 20944000
[TBL] [Abstract][Full Text] [Related]
2. GCN2 kinase plays an important role triggering the remission phase of experimental autoimmune encephalomyelitis (EAE) in mice.
Orsini H; Araujo LP; Maricato JT; Guereschi MG; Mariano M; Castilho BA; Basso AS
Brain Behav Immun; 2014 Mar; 37():177-86. PubMed ID: 24362236
[TBL] [Abstract][Full Text] [Related]
3. Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses.
Quan MY; Song XJ; Liu HJ; Deng XH; Hou HQ; Chen LP; Ma TZ; Han X; He XX; Jia Z; Guo L
J Neuroinflammation; 2019 Mar; 16(1):52. PubMed ID: 30823934
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Interferon Regulatory Factor 4 Suppresses Th1 and Th17 Cell Differentiation and Ameliorates Experimental Autoimmune Encephalomyelitis.
Yang C; He D; Yin C; Tan J
Scand J Immunol; 2015 Oct; 82(4):345-51. PubMed ID: 26110284
[TBL] [Abstract][Full Text] [Related]
5. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cells generate a CD4+CD25+Foxp3+ regulatory T cell population during the differentiation process of Th1 and Th17 cells.
Luz-Crawford P; Kurte M; Bravo-Alegría J; Contreras R; Nova-Lamperti E; Tejedor G; Noël D; Jorgensen C; Figueroa F; Djouad F; Carrión F
Stem Cell Res Ther; 2013 Jun; 4(3):65. PubMed ID: 23734780
[TBL] [Abstract][Full Text] [Related]
7. Canonical wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation.
Suryawanshi A; Manoharan I; Hong Y; Swafford D; Majumdar T; Taketo MM; Manicassamy B; Koni PA; Thangaraju M; Sun Z; Mellor AL; Munn DH; Manicassamy S
J Immunol; 2015 Apr; 194(7):3295-304. PubMed ID: 25710911
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
[TBL] [Abstract][Full Text] [Related]
9. Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Álvarez-Sánchez N; Cruz-Chamorro I; López-González A; Utrilla JC; Fernández-Santos JM; Martínez-López A; Lardone PJ; Guerrero JM; Carrillo-Vico A
Brain Behav Immun; 2015 Nov; 50():101-114. PubMed ID: 26130320
[TBL] [Abstract][Full Text] [Related]
10. C-Reactive Protein Suppresses the Th17 Response Indirectly by Attenuating the Antigen Presentation Ability of Monocyte Derived Dendritic Cells in Experimental Autoimmune Encephalomyelitis.
Shen ZY; Zheng Y; Pecsok MK; Wang K; Li W; Gong MJ; Wu F; Zhang L
Front Immunol; 2021; 12():589200. PubMed ID: 33841391
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane protects from T cell-mediated autoimmune disease by inhibition of IL-23 and IL-12 in dendritic cells.
Geisel J; Brück J; Glocova I; Dengler K; Sinnberg T; Rothfuss O; Walter M; Schulze-Osthoff K; Röcken M; Ghoreschi K
J Immunol; 2014 Apr; 192(8):3530-9. PubMed ID: 24639357
[TBL] [Abstract][Full Text] [Related]
12. IDO expressing dendritic cells suppress allograft rejection of small bowel transplantation in mice by expansion of Foxp3+ regulatory T cells.
Xie FT; Cao JS; Zhao J; Yu Y; Qi F; Dai XC
Transpl Immunol; 2015 Oct; 33(2):69-77. PubMed ID: 26002283
[TBL] [Abstract][Full Text] [Related]
13. p(⁷⁰S⁶K¹) in the TORC1 pathway is essential for the differentiation of Th17 Cells, but not Th1, Th2, or Treg cells in mice.
Sasaki CY; Chen G; Munk R; Eitan E; Martindale J; Longo DL; Ghosh P
Eur J Immunol; 2016 Jan; 46(1):212-22. PubMed ID: 26514620
[TBL] [Abstract][Full Text] [Related]
14. 1,25-dihydroxyvitamin D
Xie Z; Chen J; Zheng C; Wu J; Cheng Y; Zhu S; Lin C; Cao Q; Zhu J; Jin T
Immunology; 2017 Nov; 152(3):414-424. PubMed ID: 28617989
[TBL] [Abstract][Full Text] [Related]
15. IL-33 changes CD25
Park SH; Jung HJ; Kim TS
Immunol Lett; 2020 Feb; 218():5-10. PubMed ID: 31863784
[TBL] [Abstract][Full Text] [Related]
16. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
[TBL] [Abstract][Full Text] [Related]
17. IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells.
Curran TA; Jalili RB; Farrokhi A; Ghahary A
Immunobiology; 2014 Jan; 219(1):17-24. PubMed ID: 23891282
[TBL] [Abstract][Full Text] [Related]
18. Kirenol attenuates experimental autoimmune encephalomyelitis by inhibiting differentiation of Th1 and th17 cells and inducing apoptosis of effector T cells.
Xiao J; Yang R; Yang L; Fan X; Liu W; Deng W
Sci Rep; 2015 Mar; 5():9022. PubMed ID: 25762107
[TBL] [Abstract][Full Text] [Related]
19. Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells.
Ikeda T; Hirata S; Fukushima S; Matsunaga Y; Ito T; Uchino M; Nishimura Y; Senju S
J Immunol; 2010 Nov; 185(9):5259-67. PubMed ID: 20921531
[TBL] [Abstract][Full Text] [Related]
20. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis.
Domingues HS; Mues M; Lassmann H; Wekerle H; Krishnamoorthy G
PLoS One; 2010 Nov; 5(11):e15531. PubMed ID: 21209700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
